06.01.02
NutraStar, El Dorado Hills, CA, has received a second diabetes patent, 6,350,473, demonstrating that its stabilized rice bran derivatives reduce blood glucose levels, glycosylated hemoglobin levels and improve insulin synthesis in type 1 and type 2 diabetic subjects. This patent is owned by the RiceX Company, El Dorado Hills, CA, and is exclusively licensed to NutraStar.